nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenoxylate—OPRM1—telencephalic ventricle—Parkinson's disease	0.112	0.238	CbGeAlD
Diphenoxylate—OPRM1—nerve—Parkinson's disease	0.0705	0.15	CbGeAlD
Diphenoxylate—OPRD1—forebrain—Parkinson's disease	0.0428	0.091	CbGeAlD
Diphenoxylate—OPRM1—brainstem—Parkinson's disease	0.0303	0.0643	CbGeAlD
Diphenoxylate—OPRM1—forebrain—Parkinson's disease	0.0292	0.0621	CbGeAlD
Diphenoxylate—OPRD1—head—Parkinson's disease	0.0245	0.0521	CbGeAlD
Diphenoxylate—OPRD1—nervous system—Parkinson's disease	0.0233	0.0494	CbGeAlD
Diphenoxylate—OPRD1—central nervous system—Parkinson's disease	0.0224	0.0476	CbGeAlD
Diphenoxylate—OPRM1—G-protein activation—PDYN—Parkinson's disease	0.0205	0.0457	CbGpPWpGaD
Diphenoxylate—OPRM1—midbrain—Parkinson's disease	0.0193	0.041	CbGeAlD
Diphenoxylate—OPRM1—spinal cord—Parkinson's disease	0.0188	0.04	CbGeAlD
Diphenoxylate—OPRD1—brain—Parkinson's disease	0.0178	0.0378	CbGeAlD
Diphenoxylate—Pethidine—GRIN2B—Parkinson's disease	0.0171	0.211	CrCbGaD
Diphenoxylate—OPRM1—head—Parkinson's disease	0.0167	0.0355	CbGeAlD
Diphenoxylate—OPRM1—nervous system—Parkinson's disease	0.0159	0.0337	CbGeAlD
Diphenoxylate—OPRM1—central nervous system—Parkinson's disease	0.0153	0.0324	CbGeAlD
Diphenoxylate—OPRM1—Opioid Signalling—PPP1R1B—Parkinson's disease	0.0132	0.0295	CbGpPWpGaD
Diphenoxylate—OPRM1—brain—Parkinson's disease	0.0121	0.0257	CbGeAlD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.00985	0.022	CbGpPWpGaD
Diphenoxylate—OPRM1—Opioid Signalling—PDYN—Parkinson's disease	0.00851	0.019	CbGpPWpGaD
Diphenoxylate—Pethidine—SLC6A3—Parkinson's disease	0.0081	0.0996	CrCbGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—VIM—Parkinson's disease	0.00804	0.0179	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00771	0.0172	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.0073	0.0163	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00661	0.0147	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.00635	0.0142	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.0058	0.013	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00571	0.0128	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00565	0.0126	CbGpPWpGaD
Diphenoxylate—Clotrimazole—CYP2E1—Parkinson's disease	0.00551	0.0677	CrCbGaD
Diphenoxylate—Darifenacin—CYP2D6—Parkinson's disease	0.00538	0.0662	CrCbGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—PENK—Parkinson's disease	0.00535	0.012	CbGpPWpGaD
Diphenoxylate—Fexofenadine—CYP2D6—Parkinson's disease	0.00523	0.0644	CrCbGaD
Diphenoxylate—OPRM1—Opioid Signalling—ADRBK1—Parkinson's disease	0.0051	0.0114	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GPR37—Parkinson's disease	0.00503	0.0112	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.0049	0.0109	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0049	0.0109	CbGpPWpGaD
Diphenoxylate—Cinnarizine—DRD2—Parkinson's disease	0.00484	0.0595	CrCbGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.0047	0.0105	CbGpPWpGaD
Diphenoxylate—Sulfinpyrazone—ABCB1—Parkinson's disease	0.00453	0.0557	CrCbGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.0043	0.0096	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00426	0.0095	CbGpPWpGaD
Diphenoxylate—Pethidine—CYP2D6—Parkinson's disease	0.00425	0.0523	CrCbGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00419	0.00934	CbGpPWpGaD
Diphenoxylate—Clotrimazole—CYP2D6—Parkinson's disease	0.00404	0.0497	CrCbGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—PENK—Parkinson's disease	0.00397	0.00886	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00392	0.00875	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00389	0.00869	CbGpPWpGaD
Diphenoxylate—Fexofenadine—ABCB1—Parkinson's disease	0.00374	0.046	CrCbGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GPR37—Parkinson's disease	0.00373	0.00832	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00363	0.0081	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00359	0.00802	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GRM4—Parkinson's disease	0.00342	0.00763	CbGpPWpGaD
Diphenoxylate—Cinnarizine—CYP2D6—Parkinson's disease	0.00342	0.0421	CrCbGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00336	0.0075	CbGpPWpGaD
Diphenoxylate—Loperamide—CYP2D6—Parkinson's disease	0.00333	0.041	CrCbGaD
Diphenoxylate—OPRD1—GPCR ligand binding—PENK—Parkinson's disease	0.00324	0.00724	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00316	0.00704	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00314	0.00701	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00312	0.00696	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00308	0.00687	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00301	0.00672	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—PDYN—Parkinson's disease	0.00297	0.00662	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00292	0.00651	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00291	0.00649	CbGpPWpGaD
Diphenoxylate—Clotrimazole—ABCB1—Parkinson's disease	0.00289	0.0355	CrCbGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00289	0.00644	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00284	0.00635	CbGpPWpGaD
Diphenoxylate—OPRD1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00284	0.00634	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—GRM5—Parkinson's disease	0.00276	0.00615	CbGpPWpGaD
Diphenoxylate—OPRD1—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.0027	0.00602	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00267	0.00596	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00266	0.00594	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00264	0.00589	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00264	0.00589	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00263	0.00587	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00258	0.00576	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GPR37—Parkinson's disease	0.00258	0.00576	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00258	0.00576	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.00253	0.00566	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0025	0.00558	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00249	0.00556	CbGpPWpGaD
Diphenoxylate—Fentanyl—ABCB1—Parkinson's disease	0.00247	0.0304	CrCbGaD
Diphenoxylate—OPRM1—GPCR ligand binding—PENK—Parkinson's disease	0.0024	0.00536	CbGpPWpGaD
Diphenoxylate—Loperamide—ABCB1—Parkinson's disease	0.00238	0.0292	CrCbGaD
Diphenoxylate—Methadone—CYP2D6—Parkinson's disease	0.00237	0.0292	CrCbGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00236	0.00527	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00234	0.00523	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00233	0.0052	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00231	0.00516	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00228	0.00509	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00226	0.00504	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00226	0.00504	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00223	0.00498	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.0022	0.00491	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00216	0.00482	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00215	0.00481	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00211	0.0047	CbGpPWpGaD
Diphenoxylate—OPRM1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00211	0.0047	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00204	0.00456	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00203	0.00454	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—TAC1—Parkinson's disease	0.002	0.00447	CbGpPWpGaD
Diphenoxylate—OPRM1—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.002	0.00446	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00198	0.00442	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—DRD1—Parkinson's disease	0.00196	0.00438	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GRK5—Parkinson's disease	0.00196	0.00437	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00195	0.00436	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00195	0.00436	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00195	0.00435	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00193	0.00431	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00191	0.00427	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00191	0.00427	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00191	0.00427	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—DRD3—Parkinson's disease	0.0019	0.00425	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—IL1B—Parkinson's disease	0.00188	0.00421	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00185	0.00413	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00185	0.00412	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—VPS35—Parkinson's disease	0.00184	0.00411	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PENK—Parkinson's disease	0.00183	0.00409	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00181	0.00404	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GRM4—Parkinson's disease	0.00176	0.00392	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00175	0.00391	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00174	0.00388	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.00173	0.00386	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—DRD2—Parkinson's disease	0.00172	0.00384	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—HTR7—Parkinson's disease	0.00172	0.00384	CbGpPWpGaD
Diphenoxylate—Methadone—ABCB1—Parkinson's disease	0.00169	0.0208	CrCbGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00168	0.00374	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00167	0.00374	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00167	0.00374	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PENK—Parkinson's disease	0.00166	0.00371	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.0016	0.00356	CbGpPWpGaD
Diphenoxylate—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00158	0.00353	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00156	0.00348	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GPR37—Parkinson's disease	0.00153	0.0034	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—DGKQ—Parkinson's disease	0.00153	0.0034	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—PDYN—Parkinson's disease	0.00152	0.0034	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00151	0.00336	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00148	0.00331	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00146	0.00325	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00145	0.00324	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00143	0.0032	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—GRM5—Parkinson's disease	0.00141	0.00316	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00141	0.00315	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00139	0.00311	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—EDN1—Parkinson's disease	0.00138	0.00307	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00137	0.00306	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00136	0.00305	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00136	0.00303	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00134	0.00299	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00132	0.00296	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.0013	0.0029	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00127	0.00285	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00127	0.00285	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00124	0.00277	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.00123	0.00275	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—RIT2—Parkinson's disease	0.00122	0.00272	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR ligand binding—HTR2A—Parkinson's disease	0.0012	0.00269	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.0012	0.00269	CbGpPWpGaD
Diphenoxylate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00117	0.00262	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GRK5—Parkinson's disease	0.00116	0.00258	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00115	0.00258	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00115	0.00257	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00113	0.00253	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00113	0.00252	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00113	0.00252	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00113	0.00252	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00111	0.00248	CbGpPWpGaD
Diphenoxylate—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.0011	0.00246	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00108	0.0024	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00105	0.00234	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00104	0.00233	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GRM4—Parkinson's disease	0.00104	0.00231	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00103	0.00231	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—TAC1—Parkinson's disease	0.00103	0.00229	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00102	0.00228	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—DRD1—Parkinson's disease	0.00101	0.00225	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.001	0.00224	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PENK—Parkinson's disease	0.000983	0.00219	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MAG—Parkinson's disease	0.000983	0.00219	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000982	0.00219	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—DRD3—Parkinson's disease	0.000976	0.00218	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000972	0.00217	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000972	0.00217	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000912	0.00204	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000904	0.00202	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—PDYN—Parkinson's disease	0.000899	0.00201	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000893	0.00199	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000891	0.00199	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—DRD2—Parkinson's disease	0.000883	0.00197	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—HTR7—Parkinson's disease	0.000883	0.00197	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000857	0.00191	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000852	0.0019	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GFAP—Parkinson's disease	0.000845	0.00189	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000839	0.00187	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—GRM5—Parkinson's disease	0.000836	0.00187	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000823	0.00184	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000797	0.00178	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000778	0.00174	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000773	0.00173	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000768	0.00172	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000762	0.0017	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000747	0.00167	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000744	0.00166	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FGF20—Parkinson's disease	0.000733	0.00164	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MAG—Parkinson's disease	0.000728	0.00163	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PENK—Parkinson's disease	0.000728	0.00163	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000723	0.00162	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00072	0.00161	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00072	0.00161	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000711	0.00159	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—EDN1—Parkinson's disease	0.000707	0.00158	CbGpPWpGaD
Diphenoxylate—OPRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000681	0.00152	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000676	0.00151	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000666	0.00149	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—INSR—Parkinson's disease	0.000656	0.00146	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000654	0.00146	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000654	0.00146	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000626	0.0014	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—FGB—Parkinson's disease	0.00062	0.00138	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000619	0.00138	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000618	0.00138	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—HTR1A—Parkinson's disease	0.000617	0.00138	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—TAC1—Parkinson's disease	0.000607	0.00136	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—DRD1—Parkinson's disease	0.000595	0.00133	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000577	0.00129	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	0.000577	0.00129	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000543	0.00121	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000539	0.0012	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000527	0.00118	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000524	0.00117	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	0.000522	0.00116	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	0.000522	0.00116	CbGpPWpGaD
Diphenoxylate—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000505	0.00113	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—INSR—Parkinson's disease	0.000486	0.00108	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—FGB—Parkinson's disease	0.000459	0.00103	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000458	0.00102	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000457	0.00102	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	0.00045	0.001	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000441	0.000985	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	0.000437	0.000976	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000427	0.000954	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	0.000423	0.000943	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	0.000418	0.000932	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000399	0.000891	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000387	0.000863	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000387	0.000863	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—NGF—Parkinson's disease	0.000384	0.000857	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	0.000365	0.000815	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—APOE—Parkinson's disease	0.00034	0.000758	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000324	0.000723	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000313	0.000699	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000309	0.000691	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—INS—Parkinson's disease	0.00029	0.000648	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—NGF—Parkinson's disease	0.000284	0.000635	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000271	0.000604	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—APOE—Parkinson's disease	0.000252	0.000562	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	0.000216	0.000482	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—INS—Parkinson's disease	0.000215	0.00048	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	0.000215	0.000479	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	0.000199	0.000443	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	0.00016	0.000357	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000159	0.000355	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000147	0.000328	CbGpPWpGaD
Diphenoxylate—OPRD1—Signaling Pathways—IL6—Parkinson's disease	0.000127	0.000283	CbGpPWpGaD
Diphenoxylate—OPRM1—Signaling Pathways—IL6—Parkinson's disease	9.39e-05	0.00021	CbGpPWpGaD
